Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-019458

Chief Financial Officer acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Trigilio Jeffrey Chief Financial Officer 2024-02-22 Grant or award +50,000 133,919 D
Derivatives
Trigilio Jeffrey Chief Financial Officer 2024-02-22 Grant or award · Stock Option (Right to Buy) +100,000 100,000 D
Loading xslF345X05/ownership.xml…